NCT01301833View on ClinicalTrials.gov

Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

462

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

teneligliptin

DRUG

glinide

DRUG

biguanide

DRUG

alpha-glucosidase inhibitor

Trial Locations (1)

Unknown

Chitose-shi

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY